Understand the source comparison
Selank Amidate Cycle Length: Protocol Comparison
Different research objectives require different cycling strategies. The table below compares three evidence-based Selank Amidate cycle length protocols based on active phase duration, washout period, and ideal application. | Protocol | Active Phase | Washout P
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Different research objectives require different cycling strategies. The table below compares three evidence-based Selank Amidate cycle length protocols based on active phase duration, washout period, and ideal application.
- | Protocol | Active Phase | Washout Period | Dosing Frequency | Primary Outcome Target | Receptor Sensitivity Maintenance | Professional Assessment ||—|—|—|—|—|—|| Short Cycle | 2 weeks | 1 week | 300 mcg/day, once daily | Acute anxiolytic response without long-term neuroplasticity | Prevents measurable GABA-A downregulation | Best for short-term anxiety models; sacrifices cumulative BDNF benefits || Standard Cycle | 4 weeks | 2 weeks | 300–600 mcg/day, once daily | Balanced anxiolytic + cognitive enhancement with sustained efficacy | Allows peak BDNF accumulation before receptor adaptation becomes significant | Gold standard for multi-cycle studies; maximizes both acute and cumulative effects || Extended Cycle | 6 weeks | 3 weeks | 300 mcg/day, once daily | Maximum BDNF-driven neuroplasticity; accepts late-phase efficacy decline | Receptor downregulation evident by week 5–6; requires longer washout | Useful when cognitive outcomes outweigh anxiolytic consistency; not recommended for c
- The standard 4-week protocol dominates published research because it captures the full neuroplastic benefit window without crossing the threshold where receptor adaptation significantly weakens anxiolytic efficacy. Researchers attempting to maximize cognitive enhancement across multiple cycles should use the standard protocol rather than extending individual cycles. Three 4-week cycles with 2-week breaks produce greater cumulative BDNF effects than a single 12-week continuous administration period, which would trigger severe receptor downregulation by week eight.